Heart surgery sedative under review: could it reduce Post-Op risks?

NCT ID NCT07249164

First seen Jan 05, 2026 · Last updated May 13, 2026 · Updated 16 times

Summary

This study reviewed health records of over 400,000 adults who had heart surgery to see if giving a sedative called dexmedetomidine around the time of surgery was linked to better outcomes within 30 days. The main focus was on whether it reduced confusion (delirium) after surgery. Researchers also looked at other problems like death, kidney injury, and infections. This is an observational study, meaning it only looks at what happened in the past, not a test of a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTOPERATIVE COMPLICATIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • China Medical University Hospital

    Taichung, Taichung City, 40447, Taiwan

Conditions

Explore the condition pages connected to this study.